Digestive System Neoplasm Clinical Trials

5 recruiting

Digestive System Neoplasm Trials at a Glance

23 actively recruiting trials for digestive system neoplasm are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Houston, Hangzhou, and Cincinnati. Lead sponsors running digestive system neoplasm studies include M.D. Anderson Cancer Center, Sir Run Run Shaw Hospital, and Emory University.

Browse digestive system neoplasm trials by phase

Treatments under study

About Digestive System Neoplasm Clinical Trials

Looking for clinical trials for Digestive System Neoplasm? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Digestive System Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Digestive System Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Phase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled156 locationsNCT07222800
Recruiting

Molecular Epidemiology of Biliary Tree Cancers

CholangiocarcinomaMalignant Digestive System Neoplasm
M.D. Anderson Cancer Center1,500 enrolled1 locationNCT05179486
Recruiting

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

Malignant Female Reproductive System NeoplasmMalignant Genitourinary System NeoplasmMalignant Digestive System Neoplasm
Wake Forest University Health Sciences500 enrolled59 locationsNCT07215624
Recruiting
Not Applicable

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Esophageal CarcinomaGastric CarcinomaGastroesophageal Junction Carcinoma+7 more
Alliance for Clinical Trials in Oncology420 enrolled287 locationsNCT07283939
Recruiting
Not Applicable

EUS-guided RFA for Solid Abdominal Neoplasms

Digestive System Neoplasms
Chinese University of Hong Kong30 enrolled1 locationNCT03221335
Recruiting
Phase 2

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer

Malignant Female Reproductive System NeoplasmMalignant Digestive System Neoplasm
Mayo Clinic34 enrolled1 locationNCT06855524
Recruiting
Not Applicable

Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation in Colorectal Cancer Surgery

Gastrointestinal CancerDigestive System Neoplasms
Institute of Oncology Ljubljana60 enrolled1 locationNCT07404527
Recruiting

Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers

Malignant Digestive System Neoplasm
M.D. Anderson Cancer Center150 enrolled1 locationNCT04629677
Recruiting

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Breast CarcinomaEsophageal CarcinomaHead and Neck Carcinoma+6 more
M.D. Anderson Cancer Center5,000 enrolled1 locationNCT00991094
Recruiting
Not Applicable

Target-specific immunoPET Imaging of Digestive System Carcinoma

MalignancyLiver CancerPancreatic Cancer+12 more
RenJi Hospital400 enrolled1 locationNCT06715839
Recruiting
Phase 2

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

Malignant Digestive System Neoplasm
Emory University60 enrolled3 locationsNCT03800693
Recruiting
Not Applicable

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Metastatic Gastroesophageal Junction AdenocarcinomaMetastatic Hepatocellular CarcinomaStage IV Hepatocellular Carcinoma AJCC v8+41 more
University of California, San Francisco28 enrolled2 locationsNCT04221893
Recruiting
Not Applicable

A Clinicobiological Database in Metastatic Digestive Cancers

Digestive System Neoplasm
Institut du Cancer de Montpellier - Val d'Aurelle200 enrolled1 locationNCT03978078
Recruiting

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

NeoplasmsNeoplasms by SitePancreatic Neoplasm+5 more
OncoSil Medical Limited500 enrolled9 locationsNCT04493632
Recruiting
Not Applicable

Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.

Head and Neck NeoplasmsEsophageal NeoplasmsNeoplasms+6 more
Taipei Veterans General Hospital, Taiwan20 enrolled1 locationNCT06365866
Recruiting
Not Applicable

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

Peritoneal CarcinomatosisDigestive System NeoplasmAppendix Carcinoma by AJCC V8 Stage+4 more
Rutgers, The State University of New Jersey30 enrolled2 locationsNCT04929015
Recruiting
Not Applicable

Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors

Digestive System NeoplasmDigestive System Cancer
Renmin Hospital of Wuhan University316 enrolled1 locationNCT06223230
Recruiting
Phase 2

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Esophageal NeoplasmsDigestive System NeoplasmsEsophageal Diseases
Fujian Cancer Hospital75 enrolled1 locationNCT05624099
Recruiting
Phase 1

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms

Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06026800
Recruiting
Phase 1

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms

Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06019702